MIT Creates Optical Sensor to Track Zinc in Cells - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

MIT Creates Optical Sensor to Track Zinc in Cells


A new optical sensor created at the Massachusetts Institute of Technology (MIT) tracks zinc within cells and should help researchers learn more about its functions in cancerous cells, the university said in a press release. Measuring zinc levels may lead to a diagnostic test for early detection of prostrate cancer.  

The sensor, which can be targeted to a specific organelle within the cell, is added to cells in a laboratory dish and fluoresces when it binds to zinc, allowing scientists to determine where the metal is concentrated. The MIT chemists who designed the sensor have already used it to shed light on why zinc levels, normally high in the prostate, drop dramatically in cancerous prostate cells.

“We can use these tools to study zinc trafficking within prostate cells, both healthy and diseased. By doing so we’re trying to gain insight into how zinc levels within the cell change during the progression of prostate cancer,” says Robert Radford, an MIT postdoc who led the project and who is an author of the paper describing the sensors, which appears in the December 9th issue of the Proceedings of the National Academy of Sciences. Radford works in the lab of Stephen Lippard, the Arthur Amos Noyes Professor of Chemistry and senior author of the paper. The paper’s lead author is Wen Chyan, a 2013 MIT graduate. 

Researchers in Lippard’s laboratory are now working on exploiting similar fluorescent sensors to develop a diagnostic test for early detection of prostate cancer, which is the second leading cause of cancer death in American men, but is considered treatable if caught early enough.

A recent article published in Pharmaceutical Technology discusses other sensor technologies, including implantable and ingestible sensors that are being used to track and predict disease.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here